Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis [4]

Journal of Dermatological Science

Volumn 40, Issue 3, 2005, Pages 215-217

  Komura, Kazuhiro ^a   Fujimoto, Manabu ^a   Matsushita, Takashi ^a   Kaji, Kenzo ^a   Kondo, Miki ^a   Hirano, Takashi ^a   Orito, Hidemitsu ^a   Horikawa, Mayuka ^a   Hamaguchi, Yasuhito ^a   Hasegawa, Minoru ^a   Takehara, Kazuhiko ^a   Sato, Shinichi ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Anti Mi 2 antibodies; Dermatomyositis; Ultraviolet

Indexed keywords

ANTIBODY; MI 2 ANTIBODY; PREDNISOLONE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; BLOOD SAMPLING; CELL STRAIN K 562; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; JAPAN; LABORATORY TEST; LETTER; LOW DRUG DOSE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; DERMATOMYOSITIS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 28444478386     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2005.09.004     Document Type: Letter

References (10)

1. M. Reichlin, and M. Mattoli Description of a serological reaction characteristic of polymyositis Clin Immunol Immunopathol 5 1976 12 20
2. Q. Ge, D.S. Nilasena, C.A. O'Brien, M.B. Frank, and I.N. Targoff Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen J Clin Invest 96 1995 1730 1737
3. L.A. Love, R.L. Leff, D.D. Fraser, I.N. Targoff, M. Dalakas, and P.H Plotz A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups Medicine (Baltimore) 70 1991 360 374
4. A. Yanada, and Y. Muro A case of dermatomyositis with anti-Mi-2 antibody Jpn J Dermatol 110 2000 171 175
5. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (first of two parts) N Eng J Med 292 1975 344 348
6. R. Mierau, T. Dick, P. Bartz-Bazzanella, E. Keller, E.D. Albert, and E. Genth Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain Arthritis Rheum 39 1996 868 876
7. S. Roux, H.P. Seelig, and O. Meyer Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis J Rheumatol 25 1998 395 396
8. R. Brouwer, G.J. Hengstman, W. Vree Egberts, H. Ehrfeld, B. Bozic, and A. Ghirardello Autoantibody profiles in the sera of European patients with myositis Ann Rheum Dis 60 2001 116 123
9. I.N. Targoff, and M. Reichlin The association between Mi-2 antibodies and dermatomyositis Arthritis Rheum 28 1985 796 803
10. S. Okada, E. Weatherhead, I.N. Targoff, R. Wesley, and F.W. Miller Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease Arthritis Rheum 48 2003 2285 2293